Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC
出版年份 2019 全文链接
标题
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC
作者
关键词
-
出版物
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 38, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2019-04-26
DOI
10.1186/s13046-019-1176-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway
- (2019) Shidong Lv et al. BMC CANCER
- Thiazolidinediones as antidiabetic agents: A critical review
- (2018) M.J. Nanjan et al. BIOORGANIC CHEMISTRY
- The influence of peroxisome proliferator-activated receptor γ (PPARγ) ligands on cancer cell tumorigenicity
- (2018) Saghar Yousefnia et al. GENE
- Pivotal Roles of Peroxisome Proliferator-Activated Receptors (PPARs) and Their Signal Cascade for Cellular and Whole-Body Energy Homeostasis
- (2018) Shreekrishna Lamichane et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- The administration of peroxisome proliferator-activated receptors α/γ agonist TZD18 inhibits cell growth and induces apoptosis in human gastric cancer cell lines
- (2018) Xichao Xia et al. Journal of Cancer Research and Therapeutics
- Pioglitazone inhibits cancer cell growth through STAT3 inhibition and enhanced AIF expression via a PPARγ-independent pathway
- (2017) Masanobu Tsubaki et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Comparison of the diabetes guidelines from the ADA/EASD and the AACE/ACE
- (2017) Susan Cornell JOURNAL OF THE AMERICAN PHARMACISTS ASSOCIATION
- The Interplay between Metabolism, PPAR Signaling Pathway, and Cancer
- (2017) Daniele Fanale et al. PPAR Research
- Peroxisome Proliferator-Activated Receptor Modulation during Metabolic Diseases and Cancers: Master and Minions
- (2016) Salvatore Giovanni Vitale et al. PPAR Research
- Targeting SLC1a5-mediated glutamine dependence in non-small cell lung cancer
- (2015) Mohamed Hassanein et al. INTERNATIONAL JOURNAL OF CANCER
- ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer
- (2014) K Shimizu et al. BRITISH JOURNAL OF CANCER
- Repression of phosphoinositide-dependent protein kinase 1 expression by ciglitazone via Egr-1 represents a new approach for inhibition of lung cancer cell growth
- (2014) SWei Hann et al. Molecular Cancer
- Effect of creatine and pioglitazone on Hk-2 cell line cisplatin nephrotoxicity
- (2014) Gurkan Genc et al. RENAL FAILURE
- Pioglitazone use and the risk of bladder cancer
- (2013) Hsin-Wei Kuo et al. KAOHSIUNG JOURNAL OF MEDICAL SCIENCES
- Role of Smad2/3 and p38 MAP kinase in TGF-β1-induced epithelial-mesenchymal transition of pulmonary epithelial cells
- (2010) Irina Kolosova et al. JOURNAL OF CELLULAR PHYSIOLOGY
- PPAR-γ agonist inhibits Ang II-induced activation of dendritic cells via the MAPK and NF-κB pathways
- (2009) Zhu Wei-guo et al. IMMUNOLOGY AND CELL BIOLOGY
- Is Akt the “Warburg kinase”?—Akt-energy metabolism interactions and oncogenesis
- (2008) R. Brooks Robey et al. SEMINARS IN CANCER BIOLOGY
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started